Criminal IP ASM
Criminal IP's Attack Surface Management (ASM) is a cutting-edge platform driven by intelligence that seeks to constantly pinpoint, catalog, and supervise all internet-connected resources associated with an organization, including often ignored and shadow assets, thereby granting teams insight into their genuine external exposure as seen by potential attackers. This innovative solution combines automated asset identification with open-source intelligence (OSINT) techniques, enhancements via artificial intelligence, and advanced threat intelligence to uncover exposed hosts, domains, cloud services, IoT devices, and various other entry points on the internet, while also gathering evidence like screenshots and metadata, linking discoveries to known vulnerabilities and tactics used by attackers. By assessing exposures in terms of business significance and risk, ASM highlights vulnerable components and misconfigurations, delivering real-time alerts and interactive dashboards that streamline investigation and remediation processes. Moreover, this all-encompassing tool not only aids organizations in managing their security stance but also equips them to stay ahead of emerging threats by fostering a proactive security culture within their teams. Ultimately, the proactive management of attack surfaces can significantly enhance an organization's resilience against cyber risks.
Learn more
ManageEngine Log360
Log360 is a comprehensive security information and event management (SIEM) solution designed to address threats across on-premises, cloud, and hybrid environments. Additionally, it assists organizations in maintaining compliance with various regulations like PCI DSS, HIPAA, and GDPR. This adaptable solution can be tailored to fit specific organizational needs, ensuring the protection of sensitive information.
With Log360, users have the ability to monitor and audit a wide range of activities across their Active Directory, network devices, employee workstations, file servers, databases, Microsoft 365, and various cloud services. The system effectively correlates log data from multiple sources to identify intricate attack patterns and persistent threats. It includes advanced behavioral analytics powered by machine learning, which identifies anomalies in user and entity behavior while providing associated risk scores. More than 1000 pre-defined, actionable reports present security analytics in a clear manner, facilitating informed decision-making. Moreover, log forensics can be conducted to delve deeper into the origins of security issues, enabling a thorough understanding of the challenges faced. The integrated incident management system further enhances the solution by automating remediation responses through smart workflows and seamless integration with widely used ticketing systems. This holistic approach ensures that organizations can respond to security incidents swiftly and effectively.
Learn more
BenevolentAI
BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.
Learn more
Aspect Analytics
Aspect Analytics introduces an advanced spatial multi-omics platform that revolutionizes collaborative data analysis and management across diverse scientific fields. This innovative tool is specifically designed for research teams engaged in drug development, biomarker discovery, pathology evaluation, and various other applications, enabling them to achieve remarkable research breakthroughs. By integrating multi-omics data into a cohesive and collaborative interface, Aspect Analytics significantly boosts teamwork across different disciplines and promotes innovative thinking. Users can effortlessly merge multiple spatial omics measurements into a singular visual format, facilitating simultaneous examination of the data. The platform adeptly amalgamates information from all spatial multi-omics assays, ensuring that critical insights are easily accessible. It also boasts the ability to securely store and manage extensive datasets, scaling up to petabytes, allowing users to retrieve their information from anywhere at any time. Additionally, the platform is designed with a scalable and customizable data infrastructure that is tailored to meet specific requirements, accommodating spatial biology data from numerous technologies and vendors, irrespective of the data format. An added advantage for users is the capability to set up automated workflows, which streamline the analysis of large datasets concurrently, ultimately enhancing the efficiency of research efforts. This groundbreaking approach not only simplifies data management but also significantly increases the opportunities for scientific discovery, thereby shaping the future of research in the life sciences. As the platform continues to evolve, it promises to keep pushing the boundaries of what is possible in the realm of multi-omics research.
Learn more